India, March 21 -- Novo Nordisk said that its Annual General Meeting approved the actual remuneration of the Board of Directors for 2018 and the remuneration level for 2019, the Company's statutory Annual Report 2018. The Revised Remuneration Principles were adopted.
But a proposal from a shareholder to reduce prices if the return on equity exceeded 7%, was not adopted.
The Meeting approved re-election of Helge Lund as chairman of the Board of Directors;re-election of Jeppe Christiansen as vice chairman of the Board of
Directors.
The Meeting also approved re-election of Brian Daniels, Andreas Fibig, Sylvie Gr?goire, Liz Hewitt, Kasim Kutay and Martin Mackay as members of the Board of Directors; election of Laurence Debroux as new member o...